miRNAs and Multiple Myeloma: Focus on the Pathogenesis, Prognosis, and Drug Resistance.
- DOI
- 10.1177/15330338231202391
- Published
- 2023 Jan-Dec
- Container
- Technology in cancer research & treatment
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/15330338231202391,
title = {miRNAs and Multiple Myeloma: Focus on the Pathogenesis, Prognosis, and Drug Resistance.},
author = {Tavakoli Pirzaman A and Ebrahimi P and Hasanpour AH and Shakeri M and Babajani B and Pourali Ganji Z and Babaei H and Rahmati A and Hosseinzadeh R and Doostmohamadian S and Kazemi S},
year = {2023},
journal = {Technology in cancer research \& treatment},
doi = {10.1177/15330338231202391},
url = {https://doi.org/10.1177/15330338231202391}
}RIS
TY - JOUR TI - miRNAs and Multiple Myeloma: Focus on the Pathogenesis, Prognosis, and Drug Resistance. AU - Tavakoli Pirzaman A AU - Ebrahimi P AU - Hasanpour AH AU - Shakeri M AU - Babajani B AU - Pourali Ganji Z AU - Babaei H AU - Rahmati A AU - Hosseinzadeh R AU - Doostmohamadian S AU - Kazemi S PY - 2023 JO - Technology in cancer research & treatment DO - 10.1177/15330338231202391 UR - https://doi.org/10.1177/15330338231202391 ER -
APA
A, T. P., P, E., AH, H., M, S., B, B., Z, P. G., H, B., A, R., R, H., S, D., & S, K. (2023). miRNAs and Multiple Myeloma: Focus on the Pathogenesis, Prognosis, and Drug Resistance.. Technology in cancer research & treatment. https://doi.org/10.1177/15330338231202391
Source records
- pubmed · retrieved 2026-09-25T18:17:30.315Z